While management of locally advanced esophageal cancer has mostly involved multimodality therapy, management of clinical T2N0 patients has been more controversial, primarily as a result of inaccurate clinical staging with existing modalities. This review article examines current literature on this topic and provides recommendations for management of individual patients
Objective The objective of this prospective, nonrandomized study was to evaluate the immediate and l...
IntroductionThis study compared survival after initial treatment with esophagectomy as primary thera...
BackgroundTo investigate the role of nonsurgical treatment for early-stage esophageal cancer, we com...
Background: Staging is inaccurate for cT2N0 esophageal cancer, and patients often are clinically mis...
Esophageal adenocarcinoma has seen an increased incidence due to gastroesophageal reflux disease , s...
Esophageal adenocarcinoma has seen an increased incidence due to gastroesophageal reflux disease , s...
IntroductionThis study compared survival after initial treatment with esophagectomy as primary thera...
ObjectiveThe study objective was to develop a treatment algorithm for cT2N0M0 esophageal cancer by d...
The original publication can be found at www.springerlink.comBackground Controversy exists over the ...
Oesophageal cancer is the sixth commonest cause of overall cancer mortality. Clinical staging utiliz...
Copyright © 2015 Sebahattin Celik et al.This is an open access article distributed under theCreative...
AbstractEsophageal cancer continues to be a lethal disease with the majority of patients presenting ...
Background: The aim of this population-based cohort study was to determine whether the addition of n...
BACKGROUND To investigate the role of nonsurgical treatment for early-stage esophageal cancer, we...
BackgroundTo investigate the role of nonsurgical treatment for early-stage esophageal cancer, we com...
Objective The objective of this prospective, nonrandomized study was to evaluate the immediate and l...
IntroductionThis study compared survival after initial treatment with esophagectomy as primary thera...
BackgroundTo investigate the role of nonsurgical treatment for early-stage esophageal cancer, we com...
Background: Staging is inaccurate for cT2N0 esophageal cancer, and patients often are clinically mis...
Esophageal adenocarcinoma has seen an increased incidence due to gastroesophageal reflux disease , s...
Esophageal adenocarcinoma has seen an increased incidence due to gastroesophageal reflux disease , s...
IntroductionThis study compared survival after initial treatment with esophagectomy as primary thera...
ObjectiveThe study objective was to develop a treatment algorithm for cT2N0M0 esophageal cancer by d...
The original publication can be found at www.springerlink.comBackground Controversy exists over the ...
Oesophageal cancer is the sixth commonest cause of overall cancer mortality. Clinical staging utiliz...
Copyright © 2015 Sebahattin Celik et al.This is an open access article distributed under theCreative...
AbstractEsophageal cancer continues to be a lethal disease with the majority of patients presenting ...
Background: The aim of this population-based cohort study was to determine whether the addition of n...
BACKGROUND To investigate the role of nonsurgical treatment for early-stage esophageal cancer, we...
BackgroundTo investigate the role of nonsurgical treatment for early-stage esophageal cancer, we com...
Objective The objective of this prospective, nonrandomized study was to evaluate the immediate and l...
IntroductionThis study compared survival after initial treatment with esophagectomy as primary thera...
BackgroundTo investigate the role of nonsurgical treatment for early-stage esophageal cancer, we com...